Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

185.71
Delayed Data
As of Apr 20
 +4.37 / +2.41%
Today’s Change
147.78
Today|||52-Week Range
203.30
+0.37%
Year-to-Date

Today’s Trading

Previous close181.34
Today’s open182.85
Day’s range-- - --
Volume919,361
Average volume (3 months)1,248,652
Market cap$36.2B
Dividend yield--
Data as of 04/20/2015

Growth & Valuation

Earnings growth (last year)+156.69%
Earnings growth (this year)+12.94%
Earnings growth (next 5 years)+20.38%
Revenue growth (last year)+46.49%
P/E ratio57.0
Price/Sales16.55
Price/Book10.93

Competitors

 Today’s
change
Today’s
% change
MYLMylan NV-1.77-2.54%
VRTXVertex Pharmaceutica...+0.48+0.38%
PRGOPerrigo Company PLC-0.90-0.45%
SHPGShire+0.85+0.35%
Data as of 04/20/2015

Financials

Next reporting dateApril 23, 2015
EPS forecast (this quarter)$1.33
Annual revenue (last year)$2.2B
Annual profit (last year)$656.9M
Net profit margin29.66%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
David L. Hallal
Chief Financial Officer &
Executive Vice President
Vikas Sinha
Corporate headquarters
Cheshire, Connecticut

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers